1. Home
  2. ST vs SYRE Comparison

ST vs SYRE Comparison

Compare ST & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensata Technologies Holding plc

ST

Sensata Technologies Holding plc

HOLD

Current Price

$45.20

Market Cap

7.2B

Sector

Industrials

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$86.39

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ST
SYRE
Founded
1916
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.5B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
ST
SYRE
Price
$45.20
$86.39
Analyst Decision
Buy
Strong Buy
Analyst Count
11
12
Target Price
$42.91
$85.08
AVG Volume (30 Days)
1.8M
1.6M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
1.21%
N/A
EPS Growth
N/A
N/A
EPS
0.59
N/A
Revenue
$3,704,500,000.00
N/A
Revenue This Year
$6.47
N/A
Revenue Next Year
$4.51
N/A
P/E Ratio
$76.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.16
$14.51
52 Week High
$53.89
$102.06

Technical Indicators

Market Signals
Indicator
ST
SYRE
Relative Strength Index (RSI) 40.92 52.59
Support Level $33.15 $81.65
Resistance Level $53.30 $102.06
Average True Range (ATR) 1.70 4.79
MACD -0.70 -0.55
Stochastic Oscillator 11.75 19.59

Price Performance

Historical Comparison
ST
SYRE

About ST Sensata Technologies Holding plc

Sensata Technologies is a global supplier of sensors and electrical protection for transportation and industrial applications. Sensata sells a bevy of pressure, temperature, force, and position sensors into the automotive, heavy vehicle, industrial, heating, ventilation, and cooling, and aerospace markets. It also sells electrical protection products, like contactors and relays. The majority of the firm's revenue comes from the automotive market, where it focuses on bumper-in applications.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: